In patients with normal pretreatment , hemoglobin levels treatment with ARCON had no significant effect on @-year loco-regional control ( LRC , @ % versus @ % ; P = @ ) and disease-free survival ( DFS , @ % vs. @ % ; P = @ ) compared with accelerated radiotherapy .